Abbott has entered into an agreement with GlaxoSmithKline (GSK) to develop an automated molecular diagnostic test, based on polymerase chain reaction technology. The test is intended to screen
Rexahn Pharmaceuticals has entered into a licensing partnership with Korea Research Institute of Chemical Technology (KRICT). The deal is regarding the development of a synthetic process for Quinoxalines
AMAG has launched Feraheme (ferumoxytol) injection in the US. Feraheme is an intravenous iron replacement therapy, for the treatment of iron deficiency anemia in adult patients with chronic
Victory Pharma (Victory) has reported that the US Food and Drug Administration (FDA) has accepted the company’ New Drug Application (NDA) for MGX006, for review. The company said
Cornerstone Therapeutics has signed an asset purchase agreement with Oscient to acquire the commercial rights to the antibiotic – Factive (gemifloxacin mesylate), in North America and certain countries
Recordati has entered into an agreement with Amdipharm for marketing and sales of TransAct LAT (local action transcutaneous) in Italy and Portugal. Its a transdermal patch containing 40mg
MediciNova and the Hercules Market of the Osaka Securities Exchange have reported the proposed final protocol for phase II clinical trial (MN-221-CL-007). The trial will evaluate the safety
In its order, the Court also set to August 13, 2009 the bar date for the filing of a proof of claim. Creditors who fail to file a
The award was made under the Biotechnology Center’s Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process. “Ridge Diagnostics is
The US Food and Drug Administration has approved the blood-thinning drug Effient tablets to reduce the risk of blood clots from forming in patients who undergo angioplasty, a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.